Oral drug lowers lipoprotein(a) levels in phase 2 trial
American and Australian researchers conducted clinical trials and found that taking muvalapline effectively reduces elevated levels of lipoprotein (a) in the blood of patients with high cardiovascular risk. A report on the work was published in…